Big Pharma Split Corp.

TSX:PRM.TO

13.15 (CAD) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) CAD.

2023202220212020201920182017
Assets:
Current Assets:
Cash & Cash Equivalents 0.2040.8191.430.2310.5360.4171.846
Short Term Investments 25.53523.72835.31822.40326.33233.14430.178
Cash and Short Term Investments 0.2040.8191.430.23126.86833.56132.024
Net Receivables 0.07714.0040.1030.1040.0730.070.016
Inventory -0.718-0.545-0.964-0.194000
Other Current Assets 0.7180.5450.9640.1940.23600.448
Total Current Assets 0.28114.8231.5320.33527.17733.63132.487
Non-Current Assets:
Property, Plant & Equipment, Net 0000000
Goodwill 0000000
Intangible Assets 0000000
Goodwill and Intangible Assets 0000000
Long Term Investments 26.25324.27336.13122.44626.33233.14430.626
Tax Assets 0000000
Other Non-Current Assets -26.253-24.273-36.131-22.446-26.332-33.144-30.626
Total Non-Current Assets 26.25324.27336.13122.44626.33233.14430.626
Total Assets 26.53539.09637.81422.93327.17733.63132.487
Liabilities & Equity:
Current Liabilities:
Account Payables 0.2490.3480.3390.2130.2410.3060.21
Short Term Debt 10.2979.85414.8639.34810.58213.40913.6
Tax Payables 0000.151000
Deferred Revenue -10.049-9.507-14.524-9.1340-13.409-13.6
Other Current Liabilities -10.546-10.202-15.202-9.7120.0441.0730
Total Current Liabilities 0.2490.3480.3390.21310.86714.78813.811
Non-Current Liabilities:
Long Term Debt 0000000
Deferred Revenue Non-Current 0000000
Deferred Tax Liabilities Non-Current 0000000
Other Non-Current Liabilities 0000000
Total Non-Current Liabilities 10.6840.34815.4119.74710.8670.3060.21
Total Liabilities 0.24919.3650.3390.21310.86714.78813.811
Equity:
Preferred Stock 0000000
Common Stock 15.85119.73122.40413.18516.30918.84318.677
Retained Earnings 0000000
Accumulated Other Comprehensive Income/Loss 0000000
Other Total Stockholders Equity 0000000
Total Shareholders Equity 15.85119.73122.40413.18516.30918.84318.677
Total Equity 15.85119.73122.40413.18516.30918.84318.677
Total Liabilities & Shareholders Equity 26.53539.09637.81422.93327.17733.63132.487